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Following the publication of this paper, the authors noticed that Table S7 in the Supplemental Information contained an input error.
The value of ‘‘red blood cell’’ for the super-TDU-treated group should be ‘‘8.0 ± 0.3,’’ but was inadvertently typed as ‘‘0.8 ± 0.3.’’ The
Supplemental Information has been replaced with a corrected document online.
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